Sepsis modeling in mice: ligation length is a major severity factor in cecal ligation and puncture

Intensive Care Medicine Experimental

Volumn 4, Issue 1, 2016, Pages

  Ruiz, Stéphanie ^a,b   Vardon Bounes, Fanny ^a,b   Merlet Dupuy, Virginie ^a   Conil, Jean Marie ^a   Buléon, Marie ^b   Fourcade, Olivier ^a,c   Tack, Ivan ^a,b   Minville, Vincent ^a,b  

^a CHU RANGUEIL   (France)

^b Departments of Clinical Biochemistry and Sports Medicine   (France)

^c Plasticite Tissulaire/Metab E   (France)

Author keywords

Cecal ligation and puncture; Cytokine; Mice; Sepsis

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CECAL LIGATION AND PUNCTURE-INDUCED SEPSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; HISTOLOGY; HYPERLACTATEMIA; HYPOTENSION; INFLAMMATION; LACTATE BLOOD LEVEL; LAPAROTOMY; LEUKOCYTE COUNT; LIGATION LENGTH; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PHYSICAL PARAMETERS; PRIORITY JOURNAL; SEPTIC SHOCK;

EID: 84998866556     PISSN: None     EISSN: 2197425X     Source Type: Journal    
DOI: 10.1186/s40635-016-0096-z     Document Type: Article

References (40)

1. Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348:138–150
2. Dejager L, Pinheiro I, Dejonckheere E, Libert C (2011) Cecal ligation and puncture: the gold standard model for polymicrobial sepsis? Trends Microbiol 19:198–208
3. Roquilly A, Gautreau L, Segain JP, de Coppet P, Sebille V, Jacqueline C, Caillon J, Potel G, Lejus C, Josien R, Asehnoune K (2010) CpG-ODN and MPLA prevent mortality in a murine model of post-hemorrhage-Staphylococcus aureus pneumonia. PLoS One 5, e13228
4. Baker CC, Chaudry IH, Gaines HO, Baue AE (1983) Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 94:331–335
5. Hubbard WJ, Choudhry M, Schwacha MG, Kerby JD, Rue LW III, Bland KI, Chaudry IH (2005) Cecal ligation and puncture. Shock 24(1):52–57
6. Wichterman KA, Baue AE, Chaudry IH (1980) Sepsis and septic shock—a review of laboratory models and a proposal. J Surg Res 29:189–201
7. Deitch EA (1998) Animal models of sepsis and shock: a review and lessons learned. Shock 9:1–11
8. Remick DG, Newcomb DE, Bolgos GL, Call DR (2000) Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture. Shock 13:110–116
9. Freise H, Bruckner UB, Spiegel HU (2001) Animal models of sepsis. J Invest Surg 14:195–212
10. Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA (2009) Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 4:31–36
11. Deitch EA (2005) Rodent models of intra-abdominal infection. Shock 24(Suppl 1):19–23
12. Rittirsch D, Flierl MA, Nadeau BA, Day DE, Huber-Lang M, Mackay CR, Zetoune FS, Gerard NP, Cianflone K, Kohl J, Gerard C, Sarma JV, Ward PA (2008) Functional roles for C5a receptors in sepsis. Nat Med 14:551–557
13. Ebong S, Call D, Nemzek J, Bolgos G, Newcomb D, Remick D (1999) Immunopathologic alterations in murine models of sepsis of increasing severity. Infect Immun 67:6603–6610
14. Walley KR, Lukacs NW, Standiford TJ, Strieter RM, Kunkel SL (1996) Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect Immun 64:4733–4738
15. Singleton KD, Wischmeyer PE (2003) Distance of cecum ligated influences mortality, tumor necrosis factor-alpha and interleukin-6 expression following cecal ligation and puncture in the rat. Eur Surg Res 35:486–491
16. Reddy RC, Chen GH, Tekchandani PK, Standiford TJ (2001) Sepsis-induced immunosuppression: from bad to worse. Immunol Res 24:273–287
17. Wheeler AP, Bernard GR (1999) Treating patients with severe sepsis. N Engl J Med 340:207–214
18. Cinel I, Opal SM (2009) Molecular biology of inflammation and sepsis: a primer. Crit Care Med 37:291–304
19. Villa P, Sartor G, Angelini M, Sironi M, Conni M, Gnocchi P, Isetta AM, Grau G, Buurman W, van Tits LJ et al (1995) Pattern of cytokines and pharmacomodulation in sepsis induced by cecal ligation and puncture compared with that induced by endotoxin. Clin Diagn Lab Immunol 2:549–553
20. de Jong HK, van der Poll T, Wiersinga WJ (2010) The systemic pro-inflammatory response in sepsis. Journal of innate immunity 2:422–430
21. Torres MB, De Maio A (2005) An exaggerated inflammatory response after CLP correlates with a negative outcome. J Surg Res 125:88–93
22. Newham P, Ross D, Ceuppens P, Das S, Yates JW, Betts C, Reens J, Randall KJ, Knight R, McKay JS (2014) Determination of the safety and efficacy of therapeutic neutralization of tumor necrosis factor-alpha (TNF-alpha) using AZD9773, an anti-TNF-alpha immune Fab, in murine CLP sepsis. Inflamm Res 63:149–160
23. Eskandari MK, Bolgos G, Miller C, Nguyen DT, DeForge LE, Remick DG (1992) Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J Immunol 148:2724–2730
24. Lorente JA, Marshall JC (2005) Neutralization of tumor necrosis factor in preclinical models of sepsis. Shock 24(Suppl 1):107–119
25. Osuchowski MF, Welch K, Siddiqui J, Remick DG (2006) Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol 177:1967–1974
26. Dinarello CA (2005) Interleukin-1beta. Crit Care Med 33:S460–S462
27. Remick DG, Bolgos GR, Siddiqui J, Shin J, Nemzek JA (2002) Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days. Shock 17:463–467
28. Song M, Kellum JA (2005) Interleukin-6. Crit Care Med 33:S463–S465
29. Taniguchi T, Koido Y, Aiboshi J, Yamashita T, Suzaki S, Kurokawa A (1999) The ratio of interleukin-6 to interleukin-10 correlates with severity in patients with chest and abdominal trauma. Am J Emerg Med 17:548–551
30. Taniguchi T, Koido Y, Aiboshi J, Yamashita T, Suzaki S, Kurokawa A (1999) Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit Care Med 27:1262–1264
31. Weis F, Beiras-Fernandez A, Schelling G, Briegel J, Lang P, Hauer D, Kreth S, Kaufmann I, Lamm P, Kilger E (2009) Stress doses of hydrocortisone in high-risk patients undergoing cardiac surgery: effects on interleukin-6 to interleukin-10 ratio and early outcome. Crit Care Med 37:1685–1690
32. Welfare OoLA (2015) Public Health Service policy on humane care and use of laboratory animals. In: Editor (ed)^(eds) Book Public Health Service policy on humane care and use of laboratory animals.
33. Cotroneo TM, Hugunin KM, Shuster KA, Hwang HJ, Kakaraparthi BN, Nemzek-Hamlin JA (2012) Effects of buprenorphine on a cecal ligation and puncture model in C57BL/6 mice. J Am Assoc Lab Anim Sci 51:357–365
34. Odunayo A, Dodam JR, Kerl ME, DeClue AE (2010) Immunomodulatory effects of opioids. J Vet Emerg Crit Care 20:376–385
35. Ebong SJ, Call DR, Bolgos G, Newcomb DE, Granger JI, O’Reilly M, Remick DG (1999) Immunopathologic responses to non-lethal sepsis. Shock 12:118–126
36. Muenzer JT, Davis CG, Chang K, Schmidt RE, Dunne WM, Coopersmith CM, Hotchkiss RS (2010) Characterization and modulation of the immunosuppressive phase of sepsis. Infect Immun 78:1582–1592
37. Hotchkiss RS, Tinsley KW, Swanson PE, Chang KC, Cobb JP, Buchman TG, Korsmeyer SJ, Karl IE (1999) Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Natl Acad Sci U S A 96:14541–14546
38. Hotchkiss RS, Monneret G, Payen D (2013) Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 13:862–874
39. Turnbull IR, Wlzorek JJ, Osborne D, Hotchkiss RS, Coopersmith CM, Buchman TG (2003) Effects of age on mortality and antibiotic efficacy in cecal ligation and puncture. Shock 19:310–313
40. Wiersinga WJ (2011) Current insights in sepsis: from pathogenesis to new treatment targets. Curr Opin Crit Care 17:480–486